BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹386 Cr | ₹1,013 Cr | ₹1,023 Cr | ₹463 Cr | ₹648 Cr |
What is the latest Consolidated Net Profit of BIOCON ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹386 Cr |
| Mar2025 | ₹1,013 Cr |
| Mar2024 | ₹1,023 Cr |
| Mar2023 | ₹463 Cr |
| Mar2022 | ₹648 Cr |
How is Consolidated Net Profit of BIOCON Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹386 Cr | -61.95 | |
| Mar2025 | ₹1,013 Cr | -0.90 | |
| Mar2024 | ₹1,023 Cr | 120.99 | |
| Mar2023 | ₹463 Cr | -28.64 | |
| Mar2022 | ₹648 Cr | - | |
Compare Consolidated Net Profit of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹58,750.7 Cr | -2.8% | -9.3% | 8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.8% |
-9.3% |
8.1% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses